Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
05/19/20145:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/14/20147:00AMGlobeNewswire Inc.Sunesis to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/07/20145:05PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/07/20144:59PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/07/20144:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/07/20148:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/07/20147:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/30/20147:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on May 7th to Discuss First Quarter 2014 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/24/20144:53PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/24/20144:44PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/22/20147:00AMGlobeNewswire Inc.Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/08/20148:00AMGlobeNewswire Inc.Sunesis Announces Presentation of Positive Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk...NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/02/20147:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/02/20147:00AMGlobeNewswire Inc.Sunesis Announces MD Anderson Sponsored Trial of Vosaroxin in AML and High-Risk MDS Poster to be Presented at AACR 2014NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/24/20144:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/24/20143:48PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/11/20149:19AMPR Newswire (US)Appointments, Financial Reports, and FDA Approvals - Analyst Notes on Hospira, Karyopharm, Revance, Pluristem, and SunesisNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/06/20148:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/06/20147:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/28/20144:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/28/20148:18AMGlobeNewswire Inc.Sunesis to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/28/20148:17AMGlobeNewswire Inc.Sunesis to Host Conference Call on March 6th to Discuss Fourth Quarter and Full-Year 2013 Financial Results and Recent Highli...NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/27/20148:30AMGlobeNewswire Inc.Sunesis Announces Pricing of a $43.0 Million Public Offering of Common Stock and WarrantsNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/26/20145:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/26/20144:13PMGlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20143:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20142:11PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20146:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/13/201411:38AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/10/20148:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS